• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance - Product Image

Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance

  • ID: 2330793
  • November 2012
  • 66 Pages
  • GBI Research

GBI Research, a leading business intelligence provider, has released its latest research, “Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance”. The report focuses on the US health system’s efforts to improve patient engagement and medication adherence. Key topics of the report include reforms in the US healthcare industry, technology adoption, mobile and social media in healthcare, industry collaborations and examples of patient engagement and adherence interventions.

There is a increasing focus on medication non-adherence as a critical challenge in the US healthcare system. When patients do not adhere to their prescribed medication or treatment regimen, it leads to reduced efficiency of treatment and increased utilization of care facilities. Healthcare expenditure is rising at an exponential rate, forcing the industry to focus on efficiencies in care delivery to control costs and improve health outcomes. Health insurance reforms and new payment and reimbursement models place emphasis on outcome-based performance measures. Rising healthcare READ MORE >

Note: Product cover images may vary from those shown

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Patient Adherence, Communication and Engagement (PACE) - Introduction

3 Patient Adherence, Communication and Engagement (PACE) - Market Dynamics
3.1 Medication Non-adherence Gains Industry-wide Attention
3.2 Key Trends in Healthcare Landscape Driving Investment in Adherence Programs
3.2.1 Change Drivers in the Healthcare Industry
3.2.2 Opportunities and Challenges in the New Healthcare Landscape
3.2.3 Healthcare Reform - Increasing Access and Improving Outcomes
3.2.4 Changing Priorities in Healthcare Landscape
3.2.5 HITECH - Outlined Criteria for Meaningful Use of EHRs
3.2.6 HHS Health Data Initiative - Accessible Data is Seen as a Change Driver in Healthcare
3.3 Implications for Pharmaceutical Industry
3.4 Trends Showing the Way Forward
3.4.1 Healthcare Technology Trends
3.4.2 Medication Therapy Management
3.4.3 Shifting Gears - mHealth Leveraging Smart Phones and Personal Devices
3.4.4 Rising Prominence of Social Media and Online Networking
3.4.5 Healthcare Collaboration across Continuum of Care

4 Patient Adherence, Communication and Engagement (PACE) - Role of Collaborations
4.1 Key Stakeholders in Patient Adherence and Engagement Initiatives
4.1.1 Patient Engagement Efforts of Pharmaceutical Industry
4.1.2 Healthcare Providers
4.1.3 Health Plans
4.2 Examples of Successful Industry Collaborations
4.2.1 Employer Diabetes Program in Collaboration with Healthcare Providers and Drug Maker Achieves Patient Engagement
4.2.2 Community-wide Preventive and Disease Management Initiative by Multiple Stakeholder Alliance
4.2.3 Manufacturers Collaborate with Payers to Use Claims Data for New Drug Discovery
4.2.4 Integrated Social Media Campaign in Partnership with Patient Groups

5 Patient Adherence, Communication and Engagement (PACE) - Technology as Enabler
5.1 Healthcare IT in Promoting Adherence
5.1.1 EHR and Health Data in Monitoring and Tailoring Adherence Programs
5.1.2 PHR as a Tool to Engage Patients in Self-management
5.1.3 Technology Integration - Personal and Home Health Devices
5.1.4 Engaging Physicians and Patients with mHealth
5.1.5 Social Media Campaigns by Health Organizations and Pharmaceuticals
5.2 Case Studies - Technology Solutions Utilized in Engagement and Adherence Initiatives
5.2.1 Leveraging Existing Data from EHR for Driving Adherence Interventions
5.2.2 Engaging with the Diabetes Community through Social Media
5.2.3 Personal Devices to Promote Patient Engagement in Healthcare
5.2.4 Utilizing a Combination of Technologies for Engaging Patients in Self-management
5.2.5 Integrating Data Captured by Home Health Devices with EMR

6 Patient Adherence, Communication and Engagement (PACE) - Conclusions
6.1 Collaboration is Critical for Success in Adherence Initiatives
6.2 Technology as an Enabler for Improving Adherence

7 Patient Adherence, Communication and Engagement (PACE) - Appendix
7.1 Market Definition
7.2 Abbreviations
7.3 References
7.4 Research Methodology
7.4.1 Coverage
7.4.2 Secondary Research
7.4.3 Primary Research
7.4.4 Expert Panel Validation
7.5 Contact Us
7.6 Disclaimer

1.1 List of Tables

Table 1: PACE Industry Drivers, Challenges and Opportunities, 2012
Table 2: PACE, % of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Age, 2008
Table 3: PACE, Distribution of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Healthcare Utilization, 2008
Table 4: PACE, Mean Expenses per Person with Healthcare Expenses, The US, by Service Type, ($) 2009
Table 5: PACE, Active Prescribers Using EHRs vs. Standalone E-prescribing Systems, The US, (%), 2008-2011
Table 6: PACE, Written Summaries Provided to Beneficiaries, The US, by % of MTM Programs, 2010-2011
Table 7: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011
Table 8: PACE, Provider of MTM Services, The US, by % of MTM Programs, 2010-2011
Table 9: PACE, Subscriber Base per 100 Inhabitants, The US, by ICT Type, 2006-2011
Table 10: PACE, Social Media Presence, the US, by Hospital, 2012
Table 11: PACE, Diabetes Prevention Program, Program Outcomes, 2012
Table 12: PACE, Adult Asthma Prevalence, Michigan, by Age, 2008
Table 13: PACE, Michigan, Child Asthma Prevalence, by Age, 2008
Table 14: PACE, Diabetes Therapeutics Market, The US, Revenue ($bn), 2003-2010
Table 15: PACE, Diabetes Therapeutics Market, The US, Revenue Forecasts ($bn), 2010-2017
Table 16: PACE, Multi-channel Diabetes Campaign, Social Media Components, 2009-2012
Table 17: PACE, Multi-channel Diabetes Campaign, Social Media Performance, 2009-2012
Table 18: PACE, Adults with Diagnosed Diabetes, Georgia, % by Age, 2001-2010
Table 19: PACE, Diabetes Treatment Program, Technologies, 2008
Table 20: PACE, Hypertension Control Intervention, Technologies, 2012
Table 21: PACE, Hypertension Control Initiative, Technologies, 2012

1.2 List of Figures

Figure 1: PACE Industry Drivers, 2012
Figure 2: PACE, % of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Age, 2008
Figure 3: PACE, Distribution of Medicare FFS Beneficiaries, The US, by Number of Chronic Conditions and Healthcare Utilization, 2008
Figure 4: PACE, Mean Expenses per Person with Healthcare Expenses, The US, by Service Type, ($), 2009
Figure 5: PACE, National Health Spending, The US, by Sponsors, ($tn), 2010
Figure 6: PACE, Active Prescribers Using EHRs vs. Standalone E-prescribing Systems, The US, (%), 2008-2011
Figure 7: PACE, Written Summaries Provided to Beneficiaries, The US, by % of MTM Programs, 2010-2011
Figure 8: PACE, Beneficiary Interventions, The US, % of MTM Programs, 2010-2011
Figure 9: PACE, Provider of MTM Services, The US, by % of MTM Programs, 2010-2011
Figure 10: PACE, Subscriber Base per 100 Inhabitants, the US, by ICT Type, 2006-2011
Figure 11: PACE, FDA Guidelines on Responding to Unsolicited Information on Social Media, the US, 2011
Figure 12: PACE, Diabetes Care Program, Program Outcomes, 2007–2009
Figure 13: PACE, Pain Awareness Raising Initiative in Partnership with Patient Groups, Global, 2010
Figure 14: PACE, Adult Asthma Prevalence, Michigan, by Age, 2008
Figure 15: PACE, Child Asthma Prevalence, Michigan, by Age, 2008
Figure 16: PACE, Asthma Wellness Program, Program Outcomes, 2012
Figure 17: PACE, Diabetes Therapeutics Market, The US, Revenue Forecasts ($bn), 2003-2017
Figure 18: PACE, Adults With Diagnosed Diabetes, Georgia, % by Age, 2001-2010
Figure 19: PACE, Diabetes Treatment Program, Program Outcomes, 2008
Figure 20: PACE, Hypertension Control Initiative, Program Outcomes, 2012

Note: Product cover images may vary from those shown

Healthcare Goes Digital as Patient Adherence is Boosted by Information Technologies

Rising healthcare costs and phenomenal waste in the US healthcare system is forcing health services and industry players to re-think how care is delivered, states a new report by healthcare experts GBI Research.

The new report states that healthcare information technologies are being embraced as a way to engage patients and increase efficiency in the healthcare system, in a bid to counteract the huge costs imposed by chronic diseases.

National expenditure on healthcare in the US has surpassed 17% of Gross Domestic Product (GDP), with an aging population and changing lifestyles reflecting a growing prevalence of chronic diseases. Chronic disease healthcare costs dominate national medical expenditure, primarily due to complications resulting from patient non-adherence to treatment and medication regimens. Non-adherence is a major cause of waste in healthcare systems across the world among chronic disease patients.

Non-adherence to medication negatively affects the patient as well as the industry: the patient faces less effective treatment and increased risks of hospitalization, while struggling healthcare systems face pressure to improve patient outcomes and control costs, and the pharmaceutical industry suffers from lower prescription sales and less evidence demonstrating a drug's efficacy profile.

The engagement of patients in their own healthcare empowers them to make meaningful choices, and hence healthcare industry reforms in the US emphasize two central tenets of patient access and engagement, and coordinated care. Information and communication technologies are playing a significant role in this.

Federal stimulus is driving investments in Healthcare Information Technology (HIT), making huge amounts of data open to access, enabling data sharing and coordination in care delivery. The US Department of Health and Human Services (HHS) has mandated technology adoption by the healthcare providers, with innovation grants, incentives and penalties offered by the Health Information Technology for Economic and Clinical Health (HITECH) Act. Rapidly increasing cost burden is also forcing US health insurance providers to leverage technology and collaborations, driving the industry towards better patient engagement.

Large investments have been injected into Electronic Health Records (EHR) and other healthcare information technology systems that allow care professionals to access and share high amounts of data. There technologies also allow care providers to have better dialog with patients and engage them in managing their own health. Patients are also being targeted using other digital tools, as an increasing usage of mobile internet and social media platforms provide opportunities for engagement between patients and healthcare industry. As patients go online to seek health information and connect with support networks, there is an increased need for trusted sources for health information. Pharmaceutical companies are facilitating and participating in this online dialog to provide patients with authentic information and increasing patient engagement.

Technological advances have already demonstrated improved patient adherence, with electronic health records, e-prescribing, mHealth apps and social media campaigns all playing a part. Industry stakeholders are realizing the potential in collaborating to produce better care delivery and resource benefits, as technology and data-sharing promotes cross-industry collaborations, uniting pharmaceutical manufacturers, health insurance payers, pharmacies and employers, to build better patient engagement.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos